Below are the top medical instruments & supplies stocks on the NYSE in terms of revenue estimate for the current year.
Analysts expect Baxter International BAX to post revenue of $15.62 billion for the year ending December, 2013. Baxter's trailing-twelve-month revenue is $14.19 billion.
Thermo Fisher Scientific TMO is likely to post revenue of $12.97 billion in the year ending December, 2013. Thermo Fisher Scientific's PEG ratio is 1.17.
Covidien plc COV is expected to report revenue of $12.57 billion for the year ending September, 2013. Covidien had $1.40 billion in total cash for the latest quarter.
Becton, Dickinson and Company BDX may report revenue of $8.01 billion in the year ending September, 2013. Becton, Dickinson's trailing-twelve-month ROE is 24.60%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in